Royalty Pharma amends purchase agreement to issue Class B shares to sellers at closing

Royalty Pharma plc

Amendment No. 1 adds Royalty Pharma plc as a party to the existing Purchase Agreement.
At closing, each seller will subscribe for Class B ordinary shares equal to the Class E shares of RPH received.
Subscription price is nominal $0.000001 per share, paid in cash by sellers to the company.
Amendment facilitates the transaction to acquire all equity interests of RP LLC, disclosed in January 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.